Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.75
0.00 (0.00%)
At close: Aug 22, 2025, 12:59 PM

Iterum Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.08M -22.56M -24.77M -30.55M -28.34M -35.58M -38.37M -31.1M -56.33M -50.82M -44.43M -43.53M -10.68M 3.86M -91.56M -98.57M -114.51M -134.83M
Depreciation & Amortization
969K 626K 284K 463K 891K 1.32M 1.75M 1.75M 1.76M 1.78M 1.8M 3.13M 2.8M 2.53M 2.1M 370K 303K 157K
Stock-Based Compensation
274K 286K 363K 413K 487K 529K 784K 1.1M 1.38M 3.26M 4.76M 6.27M 7.36M 5.93M 4.32M 2.48M 1.82M 2.44M
Other Working Capital
-800.31K -2.11M -7.94M -8.9M -4.69M -3.02M 521.57K 3.13M -1.26M -3.01M 416K -1.19M -1.55M -2.47M -503K -2.18M -676K -835K
Other Non-Cash Items
9.85M 10.18M 12.31M 12.15M 10.02M 9.61M 7.98M 2.32M 24.54M 22.59M 17.09M 20.97M 100K 1.76M 8.14M 10.52M 12.87M 16M
Deferred Income Tax
n/a n/a n/a -1.57M -14.77M -13.81M -13.81M -12.24M 960K n/a n/a -3.28M -12.9M -28.55M 61.6M 67.31M 77.58M 93.24M
Change in Working Capital
-1.76M -5.19M -12.69M -13.61M -7.6M -2.32M 2.71M 7.41M 1.67M -1.46M 2.31M -235K -2.71M -3.64M -440K -4.52M -978K -5.28M
Operating Cash Flow
-14.74M -16.67M -26.69M -34.89M -41.49M -42.44M -38.94M -30.75M -26.03M -24.66M -18.47M -16.67M -16.04M -18.11M -15.84M -22.41M -22.92M -28.27M
Capital Expenditures
-2.01K -4K -2K -1.84K 1.16K -12.96K -12.96K -58.11K -68.11K -62K -62K -30K -71K -61K -61K -50K -11K -13K
Cash Acquisitions
n/a n/a n/a -15.76K -16.11K n/a n/a 11.33K -4.16K -4.43K -4.43K 9.95M 9.97M 9.95M 9.95M n/a n/a n/a
Purchase of Investments
n/a -5.85M -12.34M -17.06M -26.2M -43.32M -40.72M -45.68M -37.71M -38.29M -45.71M -42.98M -46.83M -44.42M -67.03M -60.08M -55.06M -33.92M
Sales Maturities Of Investments
6.8M 16.8M 30.5M 47.46M 51.26M 68.58M 63.88M 59.93M 67.45M 47.83M 59.73M 48.13M 40.94M 33.24M 12.34M 9.84M n/a n/a
Other Investing Acitivies
n/a 0.01 7.21M 7.21M 7.21M 7.2M -10.54K -6.11K 9.38K 9.53K 9.6M -359K 9.63M -11.5M -55.02M -45.06M -55.06M -33.92M
Investing Cash Flow
6.8M 10.95M 18.16M 30.4M 25.06M 25.25M 23.15M 14.19M 29.68M 9.47M 13.96M 5.11M -5.8M -11.08M -54.59M -50.13M -55.08M -33.93M
Debt Repayment
-14.74M -14.74M n/a n/a n/a n/a n/a n/a 72.3K 130.07K -2.12M -3.61M -5.23M -6.92M -6.3M -6.38M -6.39M -5.57M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-3.27M -8.39M n/a n/a n/a n/a n/a n/a n/a n/a n/a -136.14K -216.34K -216.34K -216.34K -8.64M -8.56M -8.56M
Financial Cash Flow
16.04M 11.06M 26.66M 13.37M 7.95M 8.01M 1.03M 878K 940.3K 798.07K -1.69M -3.75M -5.46M -6.11M 83.13M 99.88M 102.28M 105.59M
Net Cash Flow
8.05M 5.26M 18.05M 8.59M -8.76M -9.44M -15.02M -15.7M 4.5M -14.56M -6.38M -15.49M -27.39M -35.31M 12.69M 27.35M 24.31M 43.39M
Free Cash Flow
-14.74M -16.75M -26.77M -34.97M -41.56M -42.45M -38.96M -30.81M -26.09M -24.72M -18.54M -16.7M -16.11M -18.18M -15.9M -22.46M -22.93M -28.28M